164 related articles for article (PubMed ID: 1691055)
21. [Endocrine changes following progesterone substitution in early pregnancy].
Vytiska-Binstorfer E; Binder K; Huber J; Spona J
Z Geburtshilfe Perinatol; 1986; 190(4):146-8. PubMed ID: 2429465
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a choriogonadotropin beta-subunit radioimmunoassay for serum choriogonadotropin using commercially available components.
Walsh PR; Wang MC; Gittermann ML
Clin Biochem; 1980 Apr; 13(2):69-72. PubMed ID: 6156028
[TBL] [Abstract][Full Text] [Related]
23. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
24. Screening for Down's syndrome. The role of intact hCG and free subunit measurement.
Spencer K
Scand J Clin Lab Invest Suppl; 1993; 216():79-96. PubMed ID: 7690984
[TBL] [Abstract][Full Text] [Related]
25. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
26. Beta-hCG vs intact hCG assays in the detection of trophoblastic disease.
Rinker AD; Tietz NW
Clin Chem; 1989 Aug; 35(8):1799-800. PubMed ID: 2474392
[TBL] [Abstract][Full Text] [Related]
27. Bioactive to immunoreactive ratio of circulating human chorionic gonadotropin as possible evaluation for the prognosis of threatened abortion.
Camejo MI; Proverbio F; Febres F; Casart YC
Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):181-4. PubMed ID: 12860338
[TBL] [Abstract][Full Text] [Related]
28. Immunoassays for quantifying choriogonadotropin compared for assay performance and clinical application.
Witherspoon LR; Shuler SE; Joseph GF; Baird EF; Neely HR; Sonnemaker RE
Clin Chem; 1992 Jun; 38(6):887-94. PubMed ID: 1375877
[TBL] [Abstract][Full Text] [Related]
29. Free alpha-subunit, free beta-subunit of human chorionic gonadotropin (hCG), and intact hCG in sera of healthy individuals and testicular cancer patients.
Madersbacher S; Klieber R; Mann K; Marth C; Tabarelli M; Wick G; Berger P
Clin Chem; 1992 Mar; 38(3):370-6. PubMed ID: 1372196
[TBL] [Abstract][Full Text] [Related]
30. Temporal effects of maternal and pregnancy characteristics on serum pregnancy-associated plasma protein-A and free β-human chorionic gonadotropin at 7-14 weeks' gestation.
Ball S; Ekelund C; Wright D; Kirkegaard I; Nørgaard P; Petersen OB; Tabor A;
Ultrasound Obstet Gynecol; 2013 Jan; 41(1):33-9. PubMed ID: 22689065
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a dried blood spot assay to measure prenatal screening markers pregnancy-associated plasma protein a and free β-subunit of human chorionic gonadotropin.
Cowans NJ; Suonpaa M; Kouru H; Wright D; Spencer K
Clin Chem; 2013 Jun; 59(6):968-75. PubMed ID: 23426428
[TBL] [Abstract][Full Text] [Related]
32. Doubling time of human chorionic gonadotropin (hCG) in early normal pregnancy: relationship to hCG concentration and gestational age.
Fritz MA; Guo SM
Fertil Steril; 1987 Apr; 47(4):584-9. PubMed ID: 2436952
[TBL] [Abstract][Full Text] [Related]
33. The predictive value of hCG beta subunit levels in pregnancies achieved by in vitro fertilization and embryo transfer: an international collaborative study.
Confino E; Demir RH; Friberg J; Gleicher N
Fertil Steril; 1986 Apr; 45(4):526-31. PubMed ID: 2420652
[TBL] [Abstract][Full Text] [Related]
34. Human early pregnancy factor: serum concentrations before and after therapeutic abortion in comparison with beta-hCG and an early pregnancy associated protein.
Straube W; Hübel V; Loh M; Leipe S
Arch Gynecol Obstet; 1989; 246(2):115-9. PubMed ID: 2479341
[TBL] [Abstract][Full Text] [Related]
35. Total amount of circulating human chorionic gonadotrophin alpha and beta subunits in first trimester trisomies 21 and 18.
Jauniaux E; Nicolaides KH; Nagy AM; Brizot M; Meuris S
J Endocrinol; 1996 Jan; 148(1):27-31. PubMed ID: 8568468
[TBL] [Abstract][Full Text] [Related]
36. Evaluating human choriogonadotropin heterogeneity in nongestational malignancy with monoclonal immunoassays.
Hay DL; Murphy JR
Oncology; 1987; 44(3):174-9. PubMed ID: 2439967
[TBL] [Abstract][Full Text] [Related]
37. Cross-reactivity of a commercial chemiluminescence immunoassay for human chorionic gonadotropin with the free beta-subunit.
Luppa P; Spöttl G; Saller B; Neumeier D; Mann K
J Biolumin Chemilumin; 1992 Jul; 7(3):195-201. PubMed ID: 1381136
[TBL] [Abstract][Full Text] [Related]
38. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
[TBL] [Abstract][Full Text] [Related]
39. Importance of the detection method for intact dimeric human chorionic gonadotropin without interference with the free human chorionic gonadotropin beta subunit for pregnancy exclusion before liver transplantation in a woman with cholangiocarcinoma.
Massart C; Lucas C; Rioux-Leclercq N; Fergelot P; Pouvreau-Quillien V; Volatron AC
Clin Chem Lab Med; 2005; 43(8):886-9. PubMed ID: 16217885
[TBL] [Abstract][Full Text] [Related]
40. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
